NVST 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• Geopolitical conflict and tensions, such as Russia’s invasion of Ukraine, the ongoing events in the Middle East, including the conflict involving Iran, and the global response to these conflicts, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our busines…

• Our aligner business, included in our Specialty Products & Technologies segment, enters into revenue contracts that involve multiple performance obligations which include optional aligners at no additional charge. Our treatment plans are comprised of the following performance obligations: initial al…

• Our growth strategy contemplates future acquisitions, and we continually evaluate potential acquisitions that either strategically fit with our existing portfolio or expand our portfolio into new and attractive business areas. Our operations and results can be affected by the rate and extent to whic…

• During the first quarter of 2026, we updated our methodology for how we calculate changes in the sales price from period to period. Changes in sales prices are now calculated by comparing the current quarter sales prices to the full year sales price average from the prior year as it better reflects …

• All comparisons, variances, increases or decreases discussed below are for the three months ended April 3, 2026, compared to the three months ended March 28, 2025.

相对上期删除的文字 · 来源:10-Q · 2025-10-30

• Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our business, including our ability to market and sell products in the affected regions, potentially heightening our risk of cyber secur…

• We continue to monitor the evolving social, political, and economic environment in Israel and in the region for any impact to our operations. We maintain a production facility in Israel related to our Alpha-Bio Tech Implant brand. While we have experienced some volatility in the region, the Israel-H…

• Our aligner business, included in the Specialty Products & Technologies segment, enters into revenue contracts that involve multiple performance obligations which include optional aligners at no additional charge. Our treatment plans are comprised of the following performance obligations: initial al…

• All comparisons, variances, increases or decreases discussed below are for the three and nine months ended September 26, 2025, compared to the three and nine months ended September 27, 2024.

• Non-meaningful percentage change related to year-to-year comparisons are designated as NM.

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2025 10-K. The risks described in our 2025 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially ad…

• The conflict between the United States, Israel and Iran and related geopolitical instability may adversely affect our business.

• In February 2026, the United States and Israel launched coordinated military strikes against Iran, which retaliated with missile attacks across the region. The ongoing conflict and any further escalation, including additional military actions, retaliatory measures, sanctions, disruptions to trade or…

相对上期删除的文字 · 来源:10-Q · 2025-10-30

• You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2024 10-K and in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 28, 2025 (“Q1 10-Q”), which could materially affect our business, financial position, or fu…

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• (a) On May 5, 2026, our Board of Directors authorized a new stock repurchase program, pursuant to which we may purchase up to $300.0 million of our outstanding common stock through December 31, 2029. Under the stock repurchase program, we may repurchase our common stock from time to time, in amounts…

• For information about our current Repurchase Program, please refer to Part II, Item 2 “Unregistered Sales of Equity Securities and Use of Proceeds” in this Quarterly Report on Form 10-Q.

• (c) Our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) may from time to time enter into plans for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. During the quarter ended A…

• Our Senior Vice President, Strategy and Corporate Development, Mischa Reis, adopted a 10b5-1 trading plan on February 27, 2026. The adoption of such 10b5-1 trading plan occurred during an open trading window and complied with the Company’s policies on insider trading. The first trade will not occur …

• Other than as described above, during the quarter ended April 3, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of …

相对上期删除的文字 · 来源:10-Q · 2025-10-30

• (c) During the quarter ended September 26, 2025, none of the Company’s directors or officers adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as such terms are defined in Item 408(a) of Regulation S‑K under the Exchange Act.